Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-01-15
1994-05-10
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
548500, 548420, C07D20928
Patent
active
053109368
ABSTRACT:
The present invention provides a method for the treatment of inflammation and pain in a mammal requiring such treatment, comprising administering to said mammal an anti-inflammatory and analgesically effective amount of an indomethacin salt of a divalent metal capable of forming a stable complex with indomethacin, or of a pharmaceutical composition comprising said indomethacin salt together with a pharmaceutically acceptable carrier, diluent and/or excipient. The present invention also provides a process for the preparation of an indomethacin salt of a divalent metal capable of forming a stable complex with indomethacin comprising forming a solution by dissolving indomethacin and a salt of said divalent metal in a tertiary amide or cyclic tertiary amide, adding a C.sub.1-4 alkanol or C.sub.3-6 ketone to the solution to precipitate the indomethacin metal salt and separating the indomethacin metal salt precipitate from the solution. The present invention still further provides a pharmaceutical composition for alleviating inflammation and pain comprising an anti-inflammatory and analgesically effective amount of salts of indomethacin produced by the process of the invention together with a pharmaceutically acceptable carrier, diluent and/or excipient.
REFERENCES:
Weser et al., "Structure of Cu.sub.2 (indomethacin) and the reaction with superoxide in aprotic systems," Biochim. Biphys. Acta, 631, 232-45, (1980).
Ivancheva, et al., Acta Physiol. Pharmacol. Bulgaria, 14, 52 (1988).
Lewis et al., Agents Actions Supp., 1981, 8, 339-58.
Singla et al., Int'l J. Pharmaceutics, 60, 27-33 (1990).
Flower et al., The Pharmacological Basis Of Therapeutics, pp. 674-704 (Gilman et al. eds. 1985).
Shay et al., Gasroenterology, 5, 43-61 (1945).
Sorenson, J. Med. Chem., 19, 135-48 (1976).
Sorenson et al., Biol. Trace Element Res., 5, 257-73 (1983).
Barbu et al., Chemical Abstracts, vol. 100, No. 13, Abstract No. 103177 (Mar. 26, 1984).
Barbu et al., Chemical Abstracts, vol. 99, No. 13, Abstract No. 105123 (Sep. 26, 1983).
Rusanov et al., Chemical Abstracts, vol. 109, No. 17, Abstract No. 142549 (Oct. 24, 1988).
Rusanov et al., Acta Physiol. Pharmacol. Bulg., 1988, 14(1), 52-9.
Ogiso et al., Chemical And Pharmaceutical Bulletin, vol. 36, No. 2, 1988, pp. 757-762.
Lewis et al., Chemical Abstracts, vol. 96, No. 17, Abstract No. 135522 (Apr. 26, 1982).
Lewis et al., Agents Actions Supp., 1981, 8 (Trace Elem. Pathog Treat. Inflammation), 339-58.
Adsara Dalmau, Chemical Abstracts, vol. 89, No. 21, Abstract No. 186070 (Nov. 20, 1978).
Singla et al., Chemical Abstracts, vol. 113, No. 7, Abstract No. 65154 (Aug. 13, 1990).
Singla et al., Int. J. Pharm., 1990, 60(1) 27-33.
Biffin John R.
Regtop Hubertus L.
Biochemical Veterinary Research Pty. Ltd.
Springer David B.
LandOfFree
Preparation of divalent metal salts of indomethacin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of divalent metal salts of indomethacin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of divalent metal salts of indomethacin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2413420